# Phase 1 Closeout Status V0

**Status:** Evidence artifact

This file records the repository status after the Phase 1 baseline research
cycle concluded. It does not promote any strategy and does not inspect the
validation holdout.

## Current State

| Area | Status |
| --- | --- |
| Phase 1 engineering vertical slice | Complete |
| B001 research run | Rejected |
| B002 research run | Rejected |
| B003 research run | Rejected |
| Validation holdout | Uninspected |
| B001-S015, B002-S015, B003-S015 | Unrun robustness rows |
| Formal Phase 1 closeout | Pending acceptance/documentation items |

## Research Outcome

B001, B002, and B003 all failed pre-registered research-period gates before any
validation-period inspection. The project therefore has no Phase 1 strategy
candidate eligible for validation promotion.

The validation period remains:

```text
2023-01-01 through 2026-08-19
```

Do not run rejected Phase 1 configurations on this period as if it were still a
promotion test.

## Completed Foundation

- full 2016-01-01 through 2026-08-19 NSE market-data acquisition;
- full ordinary-session market-data validation;
- legacy CM to CM-UDiFF source bridge validation;
- full-window corporate-action scan and V0 adjustment rules;
- frozen V0 20-stock universe;
- frozen processed adjusted OHLCV dataset manifest;
- official Nifty 100 TRI benchmark coverage;
- Decimal portfolio accounting, cost-aware fills, T+1 execution, trade logs,
  and Phase 1 reports;
- synthetic three-trade hand reconciliation;
- B001, B002, and B003 research-period results permanently recorded.

## Remaining Closeout Items

These items should be closed before declaring Phase 1 formally complete:

- corporate-action visual-validation artifact for a real split or bonus;
- additional report statistics from the original Phase 1 specification, if
  literal report-spec completion is required;
- real Zerodha delivery cost reconciliation if a suitable broker record is
  available outside the repository;
- final Phase 1 closeout document stating that no strategy was promoted.

## Next Research Rule

Any new strategy, risk overlay, universe change, rebalance rule, cost
assumption, or parameter choice must receive a new experiment ID and be
pre-registered before execution. The 2023-2026 validation holdout remains sealed
until a genuinely new candidate passes its own research-period gates.
